Contact Us
1250 Broadway, 27th Floor, New York, NY 10001 212-619-5400 Manhattan Attorney
Manhattan Lawyer
Attorney Profiles Firm News Practice Areas Newsletters Real Estate Lawyers' Blog Clients' Rights
Best of the Best Top 100 2015 Award
Best of the Best Top 100 2016 Award

NY Real Estate Law Blog

Categories

Archives

Follow Lucas on Twitter & LinkedIn

Recent Posts in Medicine Category

KMART PLAYED FAST & LOOSE WITH DRUG PRICING

Kmart Corporation to Pay U.S. $32.3 Million to Resolve False Claims Act Allegations for Overbilling Federal Health Programs for Generic Prescription Drugs Kmart Corporation, a wholly owned subsidiary ...
Continue reading "KMART PLAYED FAST & LOOSE WITH DRUG PRICING" »

NEW HIV TREATMENT APPROVED

FDA approves first two-drug regimen for certain patients with HIV FDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human ...
Continue reading "NEW HIV TREATMENT APPROVED" »

SOLD ADULTERATED DRUGS

Former Pharmacy Compliance Director Pleads Guilty to Introducing Adulterated Drugs into Interstate Commerce and Conspiracy to Defraud the United States The former compliance director of an Indiana ...
Continue reading "SOLD ADULTERATED DRUGS" »

IV FLUID SHORTAGE

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls Update on the efforts by the ...
Continue reading "IV FLUID SHORTAGE" »

DETECTION OF PRE-DIABETES

Pre-diabetes discovery marks step towards precision medicine Predictor of metabolic disease identified by machine learning UNIVERSITY OF SYDNEY Researchers from the University of Sydney's Charles ...
Continue reading "DETECTION OF PRE-DIABETES" »

SUTENT LOWERS KIDNEY CANCER RETURN RISKS?

FDA expands approval of Sutent to reduce the risk of kidney cancer returning FDA approves adjuvant treatment for adult patients at a high risk of kidney cancer returning after nephrectomy. The U.S. ...
Continue reading "SUTENT LOWERS KIDNEY CANCER RETURN RISKS?" »

REGENERATION OF HUMAN PARTS

FDA announces comprehensive regenerative medicine policy framework Framework aims to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy ...
Continue reading "REGENERATION OF HUMAN PARTS" »

HOPE FOR PATIENTS WITH RARE BLOOD CANCER

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer The U.S. Food and Drug Administration recently expanded the approval of Zelboraf (vemurafenib) to ...
Continue reading "HOPE FOR PATIENTS WITH RARE BLOOD CANCER" »